Exchange Traded Concepts, LLC Inhibrx, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$32.76 - $39.56 $47,108 - $56,887
1,438 Added 21.45%
8,143 $284,000
Q4 2023

Jan 05, 2024
BUY
$14.5 - $38.0 $24,650 - $64,600
1,700 Added 33.97%
6,705 $254,000
Q3 2023

Oct 18, 2023
SELL
$15.75 - $26.31 $2,520 - $4,209
-160 Reduced 3.1%
5,005 $91,000
Q2 2023

Jul 20, 2023
BUY
$16.96 - $27.82 $87,598 - $143,690
5,165 New
5,165 $134,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $626M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email